NEA Management Company’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Hold |
478,548
| – | – | 0.09% | 29 |
|
|
2025
Q1 | $2.06M | Hold |
478,548
| – | – | 0.16% | 32 |
|
|
2024
Q4 | $4.12M | Sell |
478,548
-1
| -0% | -$9 | 0.23% | 33 |
|
|
2024
Q3 | $8.14M | Hold |
478,549
| – | – | 0.44% | 30 |
|
|
2024
Q2 | $7.23M | Hold |
478,549
| – | – | 0.54% | 29 |
|
|
2024
Q1 | $7.94M | Hold |
478,549
| – | – | 0.49% | 31 |
|
|
2023
Q4 | $7.66M | Hold |
478,549
| – | – | 0.51% | 31 |
|
|
2023
Q3 | $36.4M | Hold |
478,549
| – | – | 2.81% | 11 |
|
|
2023
Q2 | $28.3M | Hold |
478,549
| – | – | 2.16% | 15 |
|
|
2023
Q1 | $28.6M | Hold |
478,549
| – | – | 1.98% | 16 |
|
|
2022
Q4 | $11.2M | Sell |
478,549
-143
| -0% | -$3.33K | 0.63% | 28 |
|
|
2022
Q3 | $16M | Hold |
478,692
| – | – | 0.8% | 31 |
|
|
2022
Q2 | $12.7M | Hold |
478,692
| – | – | 0.65% | 32 |
|
|
2022
Q1 | $14.1M | Hold |
478,692
| – | – | 0.41% | 33 |
|
|
2021
Q4 | $40.9M | Hold |
478,692
| – | – | 0.83% | 20 |
|
|
2021
Q3 | $35.7M | Hold |
478,692
| – | – | 0.42% | 22 |
|
|
2021
Q2 | $44.7M | Buy |
+478,692
| New | +$44.7M | 0.58% | 25 |
|